Wenzhong Xiao

Harvard University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

51h-index15.7kcitations172works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genomics and Rare Diseases(17), Microbial Metabolic Engineering and Bioproduction(14), Molecular Biology Techniques and Applications(13), Bioinformatics and Genomic Networks(12), Biofuel production and bioconversion(11)

Publications170 total

Sirtuins and tumor immunity: mechanistic insights, immunotherapy prospects, and therapeutic horizons
Frontiers in Immunology·2025Open Access
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
UNC Libraries·2025Open Access
ME/CFS and Long COVID Pathophysiology Investigated by Invasive Cardiopulmonary Exercise Test (iCPET) and Autonomic Function Testing
2025
Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in myalgic encephalomyelitis
Journal of Translational Medicine·2025· 1 citedOpen Access
Genome-wide selection signal analysis reveals copy number variation associated with litter size in Guizhou Black goat
Frontiers in Veterinary Science·2025Open Access
Patient-reported treatment outcomes in ME/CFS and long COVID
Proceedings of the National Academy of Sciences·2025· 8 citedOpen Access
Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME/CFS and Long COVID
International Journal of Molecular Sciences·2025· 3 citedOpen Access
Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID: Commonalities Detected by Invasive Cardiopulmonary Exercise Testing
American Journal of Respiratory and Critical Care Medicine·2025
Ferroptosis-related protein biomarkers for diagnosis, differential diagnosis, and short-term mortality in patients with sepsis in the intensive care unit
Frontiers in Immunology·2025· 4 citedOpen Access
Pyridostigmine and low-dose naltrexone for ME/CFS: study protocol for the Life Improvement Trial (LIFT), a randomized, double-blind, placebo-controlled clinical trial
2025Open Access
A network medicine approach to investigating ME/CFS pathogenesis in severely ill patients: a pilot study
Frontiers in Human Neuroscience·2025· 2 citedOpen Access
Molecular profiles of blood from numerous species that differ in sensitivity to acute inflammation
Molecular Medicine·2024· 6 citedOpen Access
Patient-Reported Treatment Outcomes in ME/CFS and Long COVID
2024· 6 citedOpen Access
A Network Medicine Approach to Investigating ME/CFS Pathogenesis in Severely Ill Patients: A Pilot Study
2024Open Access
Targeted DNA-seq and RNA-seq of Reference Samples with Short-read and Long-read Sequencing
Scientific Data·2024· 6 citedOpen Access
Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME/CFS and Long COVID
2024· 2 citedOpen Access
Strong Signals of Selection for Body Size in Swine
Russian Journal of Genetics·2024
Cardiopulmonary Exercise Testing Evaluation of Long COVID
2024
Determination of Norfloxacin and Enrofloxacin in milk using deep eutectic solvent-based ferromagnetic fluid by UV-HPLC
Journal of Dispersion Science and Technology·2024· 12 cited
Multi-Omic blood analysis reveals differences in innate inflammatory sensitivity between species
2023· 3 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Ronald W. Davis(29), Ronald G. Tompkins(25), Michael Mindrinos(21), Lyle L. Moldawer(19), David Camp(15), Richard Smith(15), Weijun Qian(12), Ronald V. Maier(11), David N. Herndon(11), Henry V. Baker(10), Weihong Xu(9), Bernard H. Brownstein(9), David Schoenfeld(9), Ronald Moore(9), Celeste C. Finnerty(8), Marc G. Jeschke(8), Carol Miller‐Graziano(8), J. Perren Cobb(8), Paul E. Bankey(7), Stephen F. Lowry(7)